dr donna h ryan glp-1 ECO 24: Long-Term Weight Loss in the SELECT trial Donna Ryan, Part 3

It is a fundamentally different approach: instead of trying to force a large peptide through a hostile environment, Lilly designed a small molecule that activates the same receptor through a different structure

But for anyone abstaining from weight loss injectables for ethical or other reasons, our team may have discovered a holistic alternative

Sept 2025 Xponential Divests Lindora to Next Health Xponential sold Lindora metabolic clinics and refocused on its studio portfolio (Club Pilates, Pure Barre, Rumble, YogaSix)

PubMed Buckley, S.T., Bkdal, T.A., Vegge, A., Maarbjerg, S.J., Pyke, C., Ahnfelt-Rnne, J., Madsen, K.G., Schele, S.G., Alanentalo, T., Kirk, R.K., Pedersen, B.L., Skyggebjerg, R.B., Benie, A.J., Strauss, H.M., Wahlund, P.O., Bjerregaard, S., Farkas, E., Fekete, C., Sndergaard, F.L., Borregaard, J., Hartoft-Nielsen, M.L., & Knudsen, L.B

This peptide variant is derived from angiotensin IV

That's not necessarily saying that it is that medication